Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Winter 2022 - Critical Care
Download Issue
Share
Up Front
Publisher's Corner
Shifting to a Wellness Model of Care
By Patrick M. Schmidt
Features
Effects of COVID-19 on Medical Resources
By
Diane L.M. Cook
Fact or Fiction: Debunking the Myths Surrounding IG Therapy Improves Patient Outcomes
By
Show No Author
Interpreting Payment Rule and Revenue Cycle Terminology
By
Bonnie Kirschenbaum, MS, FASHP, FCSHP
The Rise of Metabolic Syndrome: A Cause for Concern
By
Jim Trageser
Gene Therapy for Hemoglobinopathies
By
Meredith Whitmore
Healthcare Disrupted: Transitioning Primary Care, Diagnostics and Chronic Disease Management to the Retail Healthcare Sector
By
Amy Scanlin, MS
BioTrends Watch
Washington Report
CMS Launches New Medicare.gov Tool to Compare Nursing Home Vaccination Rates
Interim Rule Advances Key Protections Against Surprise Medical Bills
HHS Announces the Availability of $25.5 Billion in COVID-19 Provider Funding
OCR Issues Guidance on HIPAA, COVID-19 Vaccinations and the Workplace
Healthcare Management
Accreditation Can Drive Business Capacity for Healthcare Organizations
Industry News
Researchers Theorize Long COVID May Be an Autoimmune Disease
IVIG Plus Glucocorticoids Effective for Treating COVID-19 Pediatric Syndrome
Kedrion to Market RYPLAZIM to Treat Rare Disease
FDA Approves Avacopan to Treat Rare Autoimmune Disease
Studies Reveal Antibody Responses of Pregnant Women Infected with SARS-CoV-2
BioFocus
Industry Insight
Universal Flu Vaccines Advance from Concept to Clinical Trials
By Keith Berman, MPH, MBA
Patient Profile
Osteoporosis: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Osteoporosis: A Physician's Perspective
By Trudie Mitschang
BioSources
BioResearch
Study Shows COVID-19 Infection Correlates with Autoimmune Markers
Transition from Clinic- to Home-Based IVIG/SCIG Is Successful to Decrease Exposure to COVID-19